Zhongliang Wang1, Bohan Yang2, Qianwen Li1, Lu Wen1, Ruiguang Zhang1. 1. Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. 2. Department of Respiratory and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Abstract
BACKGROUND: From December 2019 to February 2020, 2019 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a serious outbreak of coronavirus disease 2019 (COVID-19) in Wuhan, China. Related clinical features are needed. METHODS: We reviewed 69 patients who were hospitalized in Union hospital in Wuhan between 16 January and 29 January 2020. All patients were confirmed to be infected with SARS-CoV-2, and the final date of follow-up was 4 February 2020. RESULTS: The median age of 69 enrolled patients was 42.0 years (interquartile range 35.0-62.0), and 32 patients (46%) were men. The most common symptoms were fever (60 [87%]), cough (38 [55%]), and fatigue (29 [42%]). Most patients received antiviral therapy (66 [98.5%] of 67 patients) and antibiotic therapy (66 [98.5%] of 67 patients). As of 4 February 2020, 18 (26.9%) of 67 patients had been discharged, and 5 patients had died, with a mortality rate of 7.5%. According to the lowest SpO2 during admission, cases were divided into the SpO2 ≥ 90% group (n = 55) and the SpO2 < 90% group (n = 14). All 5 deaths occurred in the SpO2 < 90% group. Compared with SpO2 ≥ 90% group, patients of the SpO2 < 90% group were older and showed more comorbidities and higher plasma levels of interleukin (IL) 6, IL10, lactate dehydrogenase, and C reactive protein. Arbidol treatment showed tendency to improve the discharging rate and decrease the mortality rate. CONCLUSIONS: COVID-19 appears to show frequent fever, dry cough, and increase of inflammatory cytokines, and induced a mortality rate of 7.5%. Older patients or those with underlying comorbidities are at higher risk of death.
BACKGROUND: From December 2019 to February 2020, 2019 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a serious outbreak of coronavirus disease 2019 (COVID-19) in Wuhan, China. Related clinical features are needed. METHODS: We reviewed 69 patients who were hospitalized in Union hospital in Wuhan between 16 January and 29 January 2020. All patients were confirmed to be infected with SARS-CoV-2, and the final date of follow-up was 4 February 2020. RESULTS: The median age of 69 enrolled patients was 42.0 years (interquartile range 35.0-62.0), and 32 patients (46%) were men. The most common symptoms were fever (60 [87%]), cough (38 [55%]), and fatigue (29 [42%]). Most patients received antiviral therapy (66 [98.5%] of 67 patients) and antibiotic therapy (66 [98.5%] of 67 patients). As of 4 February 2020, 18 (26.9%) of 67 patients had been discharged, and 5 patients had died, with a mortality rate of 7.5%. According to the lowest SpO2 during admission, cases were divided into the SpO2 ≥ 90% group (n = 55) and the SpO2 < 90% group (n = 14). All 5 deaths occurred in the SpO2 < 90% group. Compared with SpO2 ≥ 90% group, patients of the SpO2 < 90% group were older and showed more comorbidities and higher plasma levels of interleukin (IL) 6, IL10, lactate dehydrogenase, and C reactive protein. Arbidol treatment showed tendency to improve the discharging rate and decrease the mortality rate. CONCLUSIONS:COVID-19 appears to show frequent fever, dry cough, and increase of inflammatory cytokines, and induced a mortality rate of 7.5%. Older patients or those with underlying comorbidities are at higher risk of death.
Authors: Lewis J Kaplan; Thomas P Bleck; Timothy G Buchman; R Phillip Dellinger; Clifford S Deutschman; John C Marshall; David M Maslove; Henry Masur; Margaret M Parker; Donald S Prough; Aarti Sarwal; Jonathan E Sevransky; Jean-Louis Vincent; Jerry J Zimmerman Journal: Crit Care Med Date: 2020-06-11 Impact factor: 7.598
Authors: Stephen Su Yang; Jed Lipes; Sandra Dial; Blair Schwartz; Denny Laporta; Evan Wong; Craig Baldry; Paul Warshawsky; Patricia McMillan; David Hornstein; Michel de Marchie; Dev Jayaraman Journal: CMAJ Open Date: 2020-11-24
Authors: Tyra M Avery; RaNashia L Boone; Jacky Lu; Sabrina K Spicer; Miriam A Guevara; Rebecca E Moore; Schuyler A Chambers; Shannon D Manning; Leon Dent; Dana Marshall; Steven M Damo; Steven D Townsend; Jennifer A Gaddy Journal: ACS Infect Dis Date: 2021-06-09 Impact factor: 5.084
Authors: Clinton O Ogega; Nicole E Skinner; Paul W Blair; Han-Sol Park; Kirsten Littlefield; Abhinaya Ganesan; Santosh Dhakal; Pranay Ladiwala; Annukka Ar Antar; Stuart C Ray; Michael J Betenbaugh; Andrew Pekosz; Sabra L Klein; Yukari C Manabe; Andrea L Cox; Justin R Bailey Journal: J Clin Invest Date: 2021-04-01 Impact factor: 14.808